TIGIT and acute myeloid leukemia: In addition, the study showed that TIGIT+ NK cells exhibited a lower antileukemic effect compared to TIGIT- NK cells, and AML patients with a relatively high frequency of TIGIT+ NK cells had a worse prognosis [103].